TransCode Therapeutics In...
(RNAZ)
undefined
undefined%
At close: undefined
7.42
-0.40%
After-hours Dec 13, 2024, 03:59 PM EST
undefined% (undefined)
Bid | 3.1 |
Market Cap | 5.19M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 5571.72 |
PE Ratio (ttm) | 0 |
Forward PE | n/a |
Shares Out | 696.23K |
Short % of Shares Out | undefined% |
Ask | 8.1 |
Volume | 7,553 |
Open | 7.25 |
Previous Close | 7.21 |
Day's Range | 7.24 - 7.52 |
52-Week Range | 6.63 - 264.00 |
Beta | undefined |
Shares Float | - |
Short % of Float | undefined% |
About RNAZ
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for RNAZ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Buy 0%
Hold 0%
Sell 0%